ORGANIC
LETTERS
2011
Vol. 13, No. 24
6524–6527
Deslongchamps Annulations with
Benzoquinone Monoketals
ꢀ
Denis Petrovic and Reinhard Bruckner*
€
€
Institut fu€r Organische Chemie und Biochemie, Albert-Ludwigs-Universitat,
Albertstr. 21, 79104 Freiburg im Breisgau, Germany
Received October 19, 2011
ABSTRACT
The so-called Deslongchamps annulation of deprotonated γ,δ-unsaturated β-ketoesters 15 to 2-(alkoxycarbonyl)cyclohex-2-en-1-ones or
similarly activated cyclohex-2-en-1-ones offers a versatile access to various kinds of decalindiones. The scope of Deslongchamps
annulations was extended by establishing acceptor-substituted benzoquinone monoketals such as 13 as viable substrates. They gave
octalindiones such as 35 with diastereoselectivities g 95:5.
Decalins are a structural motif from a large number of
natural products.1 The most famous decalins are the
steroid hormones.2 Tetracycline antibiotics3 are cis-octa-
lins, and there is a strong demand for new variants.4
Mevastatin, or compactin, is a hexalin, which lowered
cholesterol production in man in an unprecedented way.5
Its pharmacophore initiated the development of the statin
family6 of blockbuster drugs in the pharmaceutical indus-
try. Azadirachtin is a crop-protecting cis-decalin with a
THF bridge; it was an exceptionally tough synthetic
target.7
Reflecting this significance, decalin syntheses abound.8,9
Preferred approaches are by DielsÀAlder reactions10 or
Robinson annulations.11 The HajosÀParrishÀWiechertÀ
EderÀSauer variant12 provides enantiomerically pure oc-
talindiones that include the WielandÀMiescher ketone,13
a
key intermediate en route to synthetic steroids. Tandem
cyclizations are particularly suited for making decalins and
cyclohex-annulated or(oligocyclohex)-annulateddecalins.
(1) E. g.: (a) Breitmaier, E. Terpenes; Wiley-VCH: Weinheim, 2006. (b)
Jansen, B. J. M.; de Groot, A. Nat. Prod. Rep. 2004, 21, 449–477. (c) Wu,
Q.-X.; Shi, Y.-P.; Jia, Z.-J. Nat. Prod. Rep. 2006, 23, 699–734. (d) Fraga,
B. M. Nat. Prod. Rep. 2010, 27, 1681–1708. (e) Hill, R. A.; Connolly,
J. D. Nat. Prod. Rep. 2011, 28, 1087–1117. (f) Fraga, B. M. Nat. Prod.
Rep. 2011, 28, 1580–1610. (g) Frija, L. M. T.; Frade, R. F. M.; Afonso,
C. A. M. Chem. Rev. 2011, 111, 4418–4452. (h) Hanson, J. R. Nat. Prod.
Rep. 2011, 28, 1755–1772.
(8) Reviews: (a) Varner, M. A.; Grossman, R. B. Tetrahedron 1999,
55, 13867–13886. (b) Tokoroyama, T. Synthesis 2000, 611–633. (c)
Singh, V.; Iyer, S. R.; Pal, S. Tetrahedron 2005, 61, 9197–9231.
(9) Recent syntheses of decalin natural products include: (a) Hsu, D.-S.
Hsu, P.-Y.; Lee, Y.-C.; Liao, C.-C. J. Org. Chem. 2008, 73, 2554–2563.
(b) Fleming, F. F.; Gudipati, S. Eur. J. Org. Chem.2008, 5365–5374.
(c) Enev, V. S.; Drescher, M.; Mulzer, J. Org. Lett. 2008, 10, 413–416. (d)
(2) (a) Lednicer, L. Steroid Chemistry at a Glance; Wiley: New York,
2011. (b) Fraser, I. S. Med. J. Aust. 2000, 173, 541–544. (c) Djerassi, C.
This Man’s Pill. Reflections on the 50th Birthday of the Pill; Oxford
University Press: 2004. (d) Loose, D. S.; Stancel, G. M. Estrogens and
Progestins. In Goodman & Gilman’s The Pharmacological Basis of Ther-
apeutics, 11th ed.; Brunton, L. L., Lazo, J. S., Parker, K. L., Eds.; McGraw-
Hill: New York, 2006; pp 1541À1571.
€
Hampel, T.; Bruckner, R. Org. Lett. 2009, 11, 4842–4845. (g) Chen, K.;
Baran, P. S. Nature 2009, 459, 824–828. (e) Chen, K.; Ishihara, Y.;
ꢀ
Galan, M. M.; Baran, P. S. Tetrahedron 2010, 66, 4738–4744. (f)
References 4 and 7.
(10) Reviews: (a) Marsault, E.; Toro, A.; Nowak, P.; Deslong-
champs, P. Tetrahedron 2001, 57, 4243–4260. (b) Nicolaou, K. C.;
Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. E. Angew. Chem.,
Int. Ed. 2002, 41, 1668–1698. (c) Takao, K.; Munakata, R.; Tadano, K.
Chem. Rev. 2005, 105, 4779–4807.
(3) Nelson, M., Hillen, W., Greenwald, R. A., Eds. Tetracyclines in
€
Biology, Chemistry and Medicine; Birkhauser: Basel, 2001.
(4) Kummer, D. A.; Li, D.; Dion, A.; Myers, A. G. Chem. Sci. 2011,
2, 1710–1718.
(11) Reviews: Little, R. D.; Masjedizadeh, M. R.; Wallquist, O.;
McLoughlin, J. I. Org. React. 1995, 47, 315–552.
(5) (a) Chakravarti, R.; Sahai, V. Appl. Microbiol. Biotechnol. 2004,
64, 618–624. (b) Hudlicky, T.; Reed, J. W. The Way of Synthesis; Wiley-
(12) Hajos, Z. G.; Parrish, D. R. Ger. Pat. DE 2102623, July 29, 1971.
Eder, U.; Sauer, G.; Wiechert, R. Ger. Pat. DE 2014757, October 7, 1971.
ꢀ
VCH: Weinheim, 2007; pp 431À448.
€
(13) (a) Buchschacher, P.; Furst, A.; Gutzwiller, J. Org. Synth. Coll.
€
(6) Schafer, B. Chem. Unserer Zeit 2010, 44, 344–364.
1990, Vol. 7, 368–372. (b) Bradshaw, B.; Etxebarria-Jardı, G.; Bonjoch,
´
ꢀ
ꢀ
(7) Veitch, G. E.; Boyer, A.; Ley, S. V. Angew. Chem., Int. Ed. 2008,
47, 9402–9429.
J.; Viozquez, S. F.; Guillena, G.; Najera, C. Org. Synth. 2011, 88, 330–
341.
r
10.1021/ol202809y
Published on Web 11/15/2011
2011 American Chemical Society